0001209191-12-035026.txt : 20120622
0001209191-12-035026.hdr.sgml : 20120622
20120622110243
ACCESSION NUMBER: 0001209191-12-035026
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120620
FILED AS OF DATE: 20120622
DATE AS OF CHANGE: 20120622
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BOGER JOSHUA S
CENTRAL INDEX KEY: 0001197023
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 12921289
MAIL ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139-4242
BUSINESS PHONE: 6165776000
4
1
doc4.xml
FORM 4 SUBMISSION
X0305
4
2012-06-20
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001197023
BOGER JOSHUA S
C/O VERTEX PHARMACEUTICALS INCORPORATED
130 WAVERLY ST.
CAMBRIDGE
MA
02139
1
0
0
0
Common Stock
2012-06-20
4
M
0
4000
15.60
A
636895
D
Common Stock
2012-06-20
4
S
0
2969
57.88
D
633926
D
Common Stock
2012-06-20
4
S
0
1031
58.68
D
632895
D
Common Stock
13286
I
401(k)
Common Stock
300000
I
Common Stock held in trust.
Employee Stock Option (right to buy)
15.60
2012-06-20
4
M
0
4000
0.00
D
2013-01-17
Common Stock
4000
110951
D
Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $57.88 (range $57.46 to $58.32).
Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $58.68 (range $58.46 to $59.11).
Common stock held in grantor retained annuity trusts.
Fully vested.
Valerie L. Andrews, Attorney-In-Fact
2012-06-22